Investor Presentation - First Nine Months of 2016
Investor presentation
First nine months of 2016
Slide 35
UKPDS: Tight glycaemic control reduces risk of micro- and
macrovascular complications
Risk reduction by lowering HbA1c by 1%-point
-10
UKPDS 10 year follow-up:
Legacy effect of tight glycaemic control
Relative risk reduction of intensive vs.
conventional treatment (%)
Diabetes-
related
death
Peripheral
Myocardial Microvascular
vascular
infarction complications disease
SU/Insulin treated patients
Microvascular disease
1997
2007
25
24
Incidence risk (%)
-20
-14%
-21%*
-30
-40
*p<0.0001
-50
Source: UKPDS, Stratton et al. BMJ 2000; vol. 321:405-12
changing
diabetes®
Diabetes-related death
Myocardial infarction
-37%*
All-cause mortality
-43%*
10
10
17
16
15
6
13
Statistically significant improvement
Source: NEJM, vol. 359, Oct 2008
novo nordiskView entire presentation